Cardiovascular Therapeutics

Editorial Board

Academic Editors

  • Abdel A. Abdel-Rahman , East Carolina University, USA
  • William T. Abraham, The Ohio State University, USA
  • Matteo Anselmino, Department of Medical Sciences, University of Turin, Italy
  • Alexandros Briasoulis , University of Iowa, USA
  • James C. Coons , University of Pittsburgh School of Pharmacy, USA
  • Giuseppe De Luca , University of Eastern Piedmont, Italy
  • Leonardo De Luca , Divisione di Cardiologia Ospedale San Giovanni Evangelista, Italy
  • Masao Endoh, Yamagata University, Japan
  • Victor Garcia , New York Medical College, USA
  • Nadezhda Glezeva, UCD Conway Institute University College Dublin, Ireland
  • Christoph E. Hagemeyer , Monash University, Australia
  • Kent Hermsmeyer, Dimera Incorporated, USA
  • Rosario D. C. Hirata , University of Sao Paulo, Brazil
  • John D. Imig , Medical College of Wisconsin, USA
  • George Liu, Peking University, China
  • Joel C. Marrs , University of Colorado Anschutz Medical Campus, USA
  • Ify R. Mordi, University of Dundee, United Kingdom
  • Shaker A. Mousa , Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA
  • Nicholas B. Norgard , UMKC School of Medicine, USA
  • Nazareno Paolocci, Johns Hopkins University, USA
  • Zoltán Papp , University of Debrecen, Hungary
  • Alberto Polimeni, Division of Cardiology, Department of Medical and Surgical Sciences, “Magna Graecia” University, Catanzaro, Italy, Italy
  • Pawel Ptaszynski , Medical University Lodz, Poland
  • Prasanth Puthanveetil, Western University, Canada
  • Ursula Ravens, Dresden University of Technology, Germany
  • Kenji Sadamatsu , St. Mary's Hospital, Japan
  • Francesco Santoro , University of Foggia, Italy
  • Simona Saponara , Department of Life Sciences, University of Siena, Italy
  • Cesare M. Terracciano, Imperial College, United Kingdom
  • Brian Tomlinson , Chinese University of Hong Kong, Hong Kong
  • Haruhito A. Uchida , Okayama University Graduate School of Medicine, Japan
  • Hangang Yu , West Virginia University, USA
    Cardiovascular Therapeutics
    Publishing Collaboration
    More info
    Wiley Hindawi logo
     Journal metrics
    Acceptance rate14%
    Submission to final decision58 days
    Acceptance to publication44 days
    Impact Factor2.538

    We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.